Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005777 | peroxisome | 6 | 1 |
GO:0020015 | glycosome | 7 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3Q8INK5
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 1 |
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006633 | fatty acid biosynthetic process | 5 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity | 5 | 5 |
GO:0016229 | steroid dehydrogenase activity | 3 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 11 |
GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors | 4 | 5 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4 | 1 |
GO:0102758 | very-long-chain enoyl-CoA reductase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 7 | 11 | PF00656 | 0.612 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.417 |
CLV_NRD_NRD_1 | 222 | 224 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.306 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.242 |
CLV_PCSK_PC1ET2_1 | 146 | 148 | PF00082 | 0.242 |
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.301 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.220 |
DEG_APCC_DBOX_1 | 60 | 68 | PF00400 | 0.603 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.490 |
DOC_MAPK_gen_1 | 13 | 19 | PF00069 | 0.584 |
DOC_MAPK_gen_1 | 146 | 154 | PF00069 | 0.486 |
DOC_MAPK_gen_1 | 296 | 304 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 59 | 67 | PF00069 | 0.585 |
DOC_MAPK_MEF2A_6 | 134 | 141 | PF00069 | 0.390 |
DOC_MAPK_MEF2A_6 | 29 | 38 | PF00069 | 0.528 |
DOC_MAPK_NFAT4_5 | 134 | 142 | PF00069 | 0.390 |
DOC_PP4_FxxP_1 | 157 | 160 | PF00568 | 0.508 |
DOC_PP4_FxxP_1 | 43 | 46 | PF00568 | 0.606 |
DOC_USP7_MATH_1 | 195 | 199 | PF00917 | 0.259 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.305 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.374 |
DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.642 |
LIG_14-3-3_CanoR_1 | 40 | 44 | PF00244 | 0.497 |
LIG_APCC_ABBA_1 | 83 | 88 | PF00400 | 0.459 |
LIG_BRCT_BRCA1_1 | 186 | 190 | PF00533 | 0.301 |
LIG_BRCT_BRCA1_1 | 265 | 269 | PF00533 | 0.276 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.281 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.234 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.320 |
LIG_FHA_2 | 204 | 210 | PF00498 | 0.274 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.494 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.619 |
LIG_GBD_Chelix_1 | 107 | 115 | PF00786 | 0.390 |
LIG_LIR_Apic_2 | 102 | 106 | PF02991 | 0.278 |
LIG_LIR_Apic_2 | 42 | 46 | PF02991 | 0.599 |
LIG_LIR_Gen_1 | 176 | 185 | PF02991 | 0.297 |
LIG_LIR_Gen_1 | 253 | 259 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 176 | 180 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 198 | 203 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 253 | 257 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.305 |
LIG_PCNA_yPIPBox_3 | 231 | 242 | PF02747 | 0.301 |
LIG_Pex14_2 | 140 | 144 | PF04695 | 0.289 |
LIG_Pex14_2 | 153 | 157 | PF04695 | 0.494 |
LIG_Pex14_2 | 200 | 204 | PF04695 | 0.231 |
LIG_PTB_Apo_2 | 167 | 174 | PF02174 | 0.425 |
LIG_PTB_Phospho_1 | 167 | 173 | PF10480 | 0.425 |
LIG_REV1ctd_RIR_1 | 142 | 151 | PF16727 | 0.308 |
LIG_SH2_CRK | 103 | 107 | PF00017 | 0.278 |
LIG_SH2_CRK | 95 | 99 | PF00017 | 0.425 |
LIG_SH2_PTP2 | 136 | 139 | PF00017 | 0.351 |
LIG_SH2_SRC | 32 | 35 | PF00017 | 0.563 |
LIG_SH2_STAP1 | 131 | 135 | PF00017 | 0.297 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 136 | 139 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.291 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.225 |
LIG_SH2_STAT5 | 288 | 291 | PF00017 | 0.439 |
LIG_SH3_1 | 231 | 237 | PF00018 | 0.256 |
LIG_SH3_2 | 160 | 165 | PF14604 | 0.456 |
LIG_SH3_3 | 157 | 163 | PF00018 | 0.494 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.254 |
LIG_SH3_3 | 239 | 245 | PF00018 | 0.121 |
LIG_SUMO_SIM_par_1 | 63 | 69 | PF11976 | 0.543 |
LIG_TYR_ITIM | 84 | 89 | PF00017 | 0.493 |
LIG_TYR_ITIM | 93 | 98 | PF00017 | 0.448 |
LIG_UBA3_1 | 64 | 70 | PF00899 | 0.591 |
LIG_WRC_WIRS_1 | 174 | 179 | PF05994 | 0.278 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.425 |
MOD_CK1_1 | 253 | 259 | PF00069 | 0.338 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.657 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.330 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.559 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.465 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.275 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.322 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.378 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.294 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.283 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.584 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.289 |
MOD_NEK2_2 | 94 | 99 | PF00069 | 0.465 |
MOD_PIKK_1 | 129 | 135 | PF00454 | 0.297 |
MOD_PIKK_1 | 71 | 77 | PF00454 | 0.550 |
MOD_PK_1 | 79 | 85 | PF00069 | 0.538 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.263 |
MOD_PKA_2 | 222 | 228 | PF00069 | 0.320 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.508 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.274 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.481 |
MOD_Plk_4 | 250 | 256 | PF00069 | 0.240 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.236 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.587 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.374 |
MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.644 |
MOD_SUMO_for_1 | 145 | 148 | PF00179 | 0.450 |
MOD_SUMO_rev_2 | 22 | 31 | PF00179 | 0.506 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.325 |
TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.278 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.499 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.449 |
TRG_NLS_Bipartite_1 | 282 | 300 | PF00514 | 0.458 |
TRG_NLS_MonoExtC_3 | 281 | 286 | PF00514 | 0.505 |
TRG_NLS_MonoExtN_4 | 282 | 287 | PF00514 | 0.491 |
TRG_NLS_MonoExtN_4 | 293 | 300 | PF00514 | 0.452 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PF75 | Leptomonas seymouri | 73% | 99% |
A0A0S4IKY4 | Bodo saltans | 56% | 100% |
A0A1X0NYG0 | Trypanosomatidae | 60% | 100% |
A0A422NGL4 | Trypanosoma rangeli | 62% | 100% |
A4HEG5 | Leishmania braziliensis | 89% | 100% |
A4I1M5 | Leishmania infantum | 100% | 100% |
C9ZK67 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9AXQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
O94511 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 38% | 100% |
Q3SZ89 | Bos taurus | 30% | 84% |
Q3ZCD7 | Bos taurus | 37% | 99% |
Q4Q9R2 | Leishmania major | 96% | 100% |
Q55C17 | Dictyostelium discoideum | 38% | 100% |
Q5HYJ1 | Homo sapiens | 30% | 84% |
Q64232 | Rattus norvegicus | 36% | 99% |
Q68FF9 | Mus musculus | 22% | 100% |
Q8BFZ1 | Mus musculus | 34% | 85% |
Q99190 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 99% |
Q9CY27 | Mus musculus | 36% | 99% |
Q9M2U2 | Arabidopsis thaliana | 34% | 99% |
Q9N5Y2 | Caenorhabditis elegans | 37% | 99% |
Q9NZ01 | Homo sapiens | 37% | 99% |
Q9UT20 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 100% |